Stephen Ray Mitchell - Director, Vanda Pharmaceuticals Inc

As of June 21, 2022


What is Stephen Ray Mitchell's Net Worth?

The current estimated net worth of Vanda Pharmaceuticals Inc's Director, Stephen Ray Mitchell, is estimated to be about $496.36K . Stephen Ray Mitchell owns about 6,515 units of Vanda Pharmaceuticals Inc common stock. In the last 2 years at Vanda Pharmaceuticals Inc, Stephen Ray Mitchell has sold an estimated value of $442.69K worth.

What is Stephen Ray Mitchell's Past Insider Trading?

Stephen Ray Mitchell's largest purchase order was 19,109 units , worth over $229.94K on September 13, 2021. Stephen Ray Mitchell's largest sale order was 19,109 units , worth over $319.98K on September 13, 2021. In total, Stephen Ray Mitchell has made about 7 transactions over 2 years of their time at Vanda Pharmaceuticals Inc. Stephen Ray Mitchell usually trades in June, with the busiest year in 2021. The most recent transaction was a sale order of 2,700 units , worth over $25.59K on June 14, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Stephen Ray Mitchell's' Mailing Address?

  • Mailing address is C/o Vanda Pharmaceuticals Inc. 2200 Pennsylvania Ave., Suite 300e Washington DC 20037 DC

Vanda Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mihael H. Polymeropoulos, M.D. 2020 $746,235 - $679,200 $795,830 $656,687 $35,468 $2,913,420
Mihael H. Polymeropoulos, M.D. 2019 $721,000 - $1,237,200 $1,610,154 $675,000 $34,783 $4,278,137
Mihael H. Polymeropoulos, M.D. 2018 $700,000 - $1,131,000 $1,456,406 $700,000 $37,322 $4,024,728
James P. Kelly 2020 $124,057 - - - - $16,217 $140,274
James P. Kelly 2019 $493,370 - $618,600 $805,077 $288,622 $42,741 $2,248,410
James P. Kelly 2018 $479,000 - $754,000 $832,232 $299,375 $36,778 $2,401,385
Kevin Moran 2020 $324,693 - $331,101 $427,779 $200,000 $36,126 $1,319,699
Joakim Wijkstrom 2020 $506,422 - $339,600 $397,915 $250,679 $29,269 $1,523,885
Aranthan "AJ" Jones II 2020 $406,104 - $339,600 $397,915 $201,021 $33,677 $1,378,317
Timothy Williams 2020 $400,000 - $339,600 $397,915 $200,000 $41,546 $1,379,061
Timothy Williams 2019 $379,315 - $618,600 $805,077 $177,520 $42,342 $2,022,854
Timothy Williams 2018 $144,886 $40,000 $643,500 $1,086,894 $71,918 $15,658 $2,002,856
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm

What are Vanda Pharmaceuticals Inc's Past Insider Trades?

Vanda Pharmaceuticals Inc's most recent insider trade came on June 14, 2022 by Stephen Ray Mitchell who sold 2,700 units worth $25.59K . In the last 16 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $295.94M and bought an estimated value of $28.25M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO,  James P. Kelly, EVP & Chief Financial Officer,  and Richard W Dugan, Director .

Vanda Pharmaceuticals Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1